Insights

Innovative Industry Leadership Abzena's recognition as a leader in both innovation and growth within the ADC CDMO market highlights its strong market positioning. This presents opportunities to collaborate on cutting-edge biologics projects and expand service offerings to clients seeking advanced development and manufacturing solutions.

Strategic Collaborations Recent integration with Mabqi SAS enhances Abzena's antibody discovery and development capabilities, making it an attractive partner for biotech firms looking for streamlined, end-to-end drug development services and innovative therapeutic platforms.

Facility Expansion The company's recent expansion of facilities and advanced microbiology testing capabilities in San Diego indicates a capacity for handling larger-scale projects, creating opportunities to target clients with growing manufacturing and regulatory needs in biologics and bioconjugates.

Product Innovation The launch of next-generation glutamine synthetase knockout platforms and double knockout ADCC+ systems demonstrates Abzena’s commitment to innovative biologics solutions, presenting potential upselling opportunities with clients seeking cutting-edge expression and cell line development tools.

Financial Backing & Growth With $65 million in funding and a strong global footprint across high-growth markets, Abzena is well-positioned to scale its services and invest in new technologies, offering sales teams opportunities to target emerging biopharma clients and expand into new therapeutic areas.

Abzena Tech Stack

Abzena uses 8 technology products and services including LiveIntent, jsDelivr, Salesforce, and more. Explore Abzena's tech stack below.

  • LiveIntent
    Advertising
  • jsDelivr
    Content Delivery Network
  • Salesforce
    Customer Relationship Management
  • Font Awesome
    Font Scripts
  • Isotope
    Javascript Libraries
  • Select2
    Javascript Libraries
  • PWA
    Miscellaneous
  • Nginx
    Web Servers

Media & News

Abzena's Email Address Formats

Abzena uses at least 1 format(s):
Abzena Email FormatsExamplePercentage
First.Last@abzena.comJohn.Doe@abzena.com
99%
Last@abzena.comDoe@abzena.com
1%

Frequently Asked Questions

Where is Abzena's headquarters located?

Minus sign iconPlus sign icon
Abzena's main headquarters is located at 6325 Lusk Boulevard San Diego, California 92121 United States. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Abzena's phone number?

Minus sign iconPlus sign icon
You can contact Abzena's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Abzena's official website and social media links?

Minus sign iconPlus sign icon
Abzena's official website is abzena.com and has social profiles on LinkedInCrunchbase.

What is Abzena's NAICS code?

Minus sign iconPlus sign icon
Abzena's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Abzena have currently?

Minus sign iconPlus sign icon
As of April 2026, Abzena has approximately 419 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. G.Chief Scientific Officer: C. B.Chief Financial Officer: T. C.. Explore Abzena's employee directory with LeadIQ.

What industry does Abzena belong to?

Minus sign iconPlus sign icon
Abzena operates in the Pharmaceutical Manufacturing industry.

What technology does Abzena use?

Minus sign iconPlus sign icon
Abzena's tech stack includes LiveIntentjsDelivrSalesforceFont AwesomeIsotopeSelect2PWANginx.

What is Abzena's email format?

Minus sign iconPlus sign icon
Abzena's email format typically follows the pattern of First.Last@abzena.com. Find more Abzena email formats with LeadIQ.

How much funding has Abzena raised to date?

Minus sign iconPlus sign icon
As of April 2026, Abzena has raised $65M in funding. The last funding round occurred on Mar 31, 2022 for $65M.

When was Abzena founded?

Minus sign iconPlus sign icon
Abzena was founded in 2001.

Abzena

Pharmaceutical ManufacturingCalifornia, United States201-500 Employees

Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO.  From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.

Section iconCompany Overview

Headquarters
6325 Lusk Boulevard San Diego, California 92121 United States
Phone number
Website
abzena.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2001
Employees
201-500

Section iconFunding & Financials

  • $65M

    Abzena has raised a total of $65M of funding over 5 rounds. Their latest funding round was raised on Mar 31, 2022 in the amount of $65M.

Section iconFunding & Financials

  • $65M

    Abzena has raised a total of $65M of funding over 5 rounds. Their latest funding round was raised on Mar 31, 2022 in the amount of $65M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.